Skip to main content
Premium Trial:

Request an Annual Quote

The Effectiveness of Comparing Effectiveness

Pharmalot's Ed Silverman discusses the results of the National Pharmaceutical Council's recent survey on comparative effectiveness research and why, according to the data, the concept doesn't appear to be a "potent" one. In surveying 111 individuals at federal agencies, in consumer and trade groups, and in academia, among other places, the NPC — a pharma-supported policy research organization — found that nearly 60 percent considered themselves "very familiar" with comparative effectiveness research, though only 30 percent indicated they felt that it would "lead to moderate improvements in health care decision-making in the next year," Silverman says. In addition, he says, the NPC found that among its 111 participants, 85 percent indicated they felt that comparative effectiveness research "led to little or no improvement for health care decision-making in the past year," 11 percent said it had "led to moderate improvements," and 30 percent indicated they thought it "would lead to moderate improvements in health care decision-making in the next year."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.